Anti-inflammatory and liver sulfhydryl content-altering effects of certain nonsteroids in the rat.
D000470:Alkaloids / Q000494:pharmacology / Q000627:therapeutic use; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology / Q000627:therapeutic use*; D001241:Aspirin / Q000494:pharmacology / Q000627:therapeutic use; D002351:Carrageenan / Q000037:antagonists & inhibitors; D002746:Chlorpromazine / Q000494:pharmacology / Q000627:therapeutic use; D003533:Cyproheptadine / Q000494:pharmacology / Q000627:therapeutic use; D004487:Edema / Q000139:chemically induced / Q000517:prevention & control*; D007213:Indomethacin / Q000494:pharmacology / Q000627:therapeutic use; D008099:Liver / Q000378:metabolism*; D008297:Male; D010653:Phenylbutazone / Q000494:pharmacology / Q000627:therapeutic use; D051381:Rats; D012663:Semicarbazides / Q000494:pharmacology / Q000627:therapeutic use; D013034:Sparteine / Q000494:pharmacology / Q000627:therapeutic use; D013438:Sulfhydryl Compounds / Q000378:metabolism*; D013747:Tetrabenazine / Q000494:pharmacology / Q000627:therapeutic use
D000470:Alkaloids; D000893:Anti-Inflammatory Agents; D012663:Semicarbazides; D013438:Sulfhydryl Compounds; D013034:Sparteine; D003533:Cyproheptadine; D002351:Carrageenan; D010653:Phenylbutazone; D001241:Aspirin; D002746:Chlorpromazine; D007213:Indomethacin; D013747:Tetrabenazine